Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodora S Ross

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Cancer Research|April 19, 2007
Huntingtin interacting protein 1 is a novel brain tumor marker that associates with epidermal growth factor receptorSarah V Bradley, Eric C Holland, Grace Y Liu, et al.
JCI Insight|November 8, 2022
BRCA1 and TP53 codeficiency causes a PARP inhibitor-sensitive erythroproliferative neoplasmGerardo Lopez-Perez, Ranjula Wijayatunge, Kelly B McCrum, et al.
JCO Precision Oncology|September 14, 2020
Impact of a Cancer Gene Variant Reclassification Program Over a 20-Year PeriodLisa Esterling, Ranjula Wijayatunge, Krystal Brown, et al.
Cancer Research|February 19, 2008
Use of a cryptic splice site for the expression of huntingtin interacting protein 1 in select normal and neoplastic tissuesChiron W Graves, Steven T Philips, Sarah V Bradley, et al.
Molecular and Cellular Biology|September 19, 2018
Deficiency of the Endocytic Protein Hip1 Leads to Decreased Ranjula Wijayatunge, Sam R Holmstrom, Samantha B Foley, et al.
Molecular and Cellular Biology|July 10, 2013
Huntingtin-interacting protein 1 phosphorylation by receptor tyrosine kinasesHeather M Ames, Anmin A Wang, Alanna Coughran, et al.
Cell Reports|October 8, 2013
Expression of BCR/ABL p210 from a knockin allele enhances bone marrow engraftment without inducing neoplasiaSamantha B Foley, Zacariah L Hildenbrand, Abigail A Soyombo, et al.
Ebiomedicine|May 30, 2015
Use of Whole Genome Sequencing for Diagnosis and Discovery in the Cancer Genetics ClinicSamantha B Foley, Jonathan J Rios, Victoria E Mgbemena, et al.
Stem Cell Reports|December 10, 2013
Analysis of induced pluripotent stem cells from a BRCA1 mutant familyAbigail A Soyombo, Yipin Wu, Lauren Kolski, et al.
Ebiomedicine|April 1, 2015
Decreased <i>BECN1</i> mRNA Expression in Human Breast Cancer is Associated with Estrogen Receptor-Negative Subtypes and Poor PrognosisHao Tang, Salwa Sebti, Rossella Titone, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Cancer Research|April 19, 2007
Huntingtin interacting protein 1 is a novel brain tumor marker that associates with epidermal growth factor receptorSarah V Bradley, Eric C Holland, Grace Y Liu, et al.
JCI Insight|November 8, 2022
BRCA1 and TP53 codeficiency causes a PARP inhibitor-sensitive erythroproliferative neoplasmGerardo Lopez-Perez, Ranjula Wijayatunge, Kelly B McCrum, et al.
JCO Precision Oncology|September 14, 2020
Impact of a Cancer Gene Variant Reclassification Program Over a 20-Year PeriodLisa Esterling, Ranjula Wijayatunge, Krystal Brown, et al.
Cancer Research|February 19, 2008
Use of a cryptic splice site for the expression of huntingtin interacting protein 1 in select normal and neoplastic tissuesChiron W Graves, Steven T Philips, Sarah V Bradley, et al.
Molecular and Cellular Biology|September 19, 2018
Deficiency of the Endocytic Protein Hip1 Leads to Decreased Ranjula Wijayatunge, Sam R Holmstrom, Samantha B Foley, et al.
Molecular and Cellular Biology|July 10, 2013
Huntingtin-interacting protein 1 phosphorylation by receptor tyrosine kinasesHeather M Ames, Anmin A Wang, Alanna Coughran, et al.
Cell Reports|October 8, 2013
Expression of BCR/ABL p210 from a knockin allele enhances bone marrow engraftment without inducing neoplasiaSamantha B Foley, Zacariah L Hildenbrand, Abigail A Soyombo, et al.
Ebiomedicine|May 30, 2015
Use of Whole Genome Sequencing for Diagnosis and Discovery in the Cancer Genetics ClinicSamantha B Foley, Jonathan J Rios, Victoria E Mgbemena, et al.
Stem Cell Reports|December 10, 2013
Analysis of induced pluripotent stem cells from a BRCA1 mutant familyAbigail A Soyombo, Yipin Wu, Lauren Kolski, et al.
Ebiomedicine|April 1, 2015
Decreased <i>BECN1</i> mRNA Expression in Human Breast Cancer is Associated with Estrogen Receptor-Negative Subtypes and Poor PrognosisHao Tang, Salwa Sebti, Rossella Titone, et al.
Pageof 4